Published in J Biol Chem on September 10, 2008
Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. J Biol Chem (2010) 1.18
FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization. J Biol Chem (2009) 1.16
Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice. J Biol Chem (2013) 0.94
Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med (2010) 0.93
Molecular regulation of matrix extracellular phosphoglycoprotein expression by bone morphogenetic protein-2. J Biol Chem (2009) 0.91
The canonical BMP signaling pathway plays a crucial part in stimulation of dentin sialophosphoprotein expression by BMP-2. J Biol Chem (2010) 0.87
PIAS1 negatively regulates ubiquitination of Msx1 homeoprotein independent of its SUMO ligase activity. Mol Cells (2011) 0.79
MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling. Cell Res (2015) 0.75
Large parietal midline defect with unusual ridge-like structure at the rim and persistent falcine sinus. Childs Nerv Syst (2013) 0.75
Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem (2006) 2.15
BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem (2003) 2.01
BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun (2003) 1.97
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res (2005) 1.87
Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. Biomaterials (2006) 1.86
Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res (2003) 1.77
Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol (2007) 1.73
Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling. Clin Chem Lab Med (2005) 1.68
The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem (2002) 1.66
NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci U S A (2004) 1.66
Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem (2005) 1.56
Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep (2008) 1.47
Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics (2007) 1.35
Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem (2004) 1.34
Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis. Dev Biol (2004) 1.32
BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem (2010) 1.22
Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. J Biol Chem (2010) 1.18
FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization. J Biol Chem (2009) 1.16
Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J Cell Physiol (2006) 1.16
Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn (2005) 1.12
Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways. Proteomics (2006) 1.12
Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. J Cell Physiol (2008) 1.11
BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription. J Biol Chem (2011) 1.10
Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK. FEBS Lett (2006) 1.09
The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells. Gene (2005) 1.08
Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum (2003) 1.08
Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer. J Proteome Res (2011) 1.08
MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer. Cancer Lett (2013) 1.06
The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J (2005) 1.06
Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases. Brain Res (2009) 1.04
Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution. PLoS One (2012) 1.03
Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis. Exp Mol Med (2007) 1.02
Comparative evaluation of nanofibrous scaffolding for bone regeneration in critical-size calvarial defects. Tissue Eng Part A (2009) 1.02
Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. J Proteome Res (2010) 1.01
Blockage of NF-kappaB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells. Cell Cycle (2005) 1.01
The odontogenic ameloblast-associated protein (ODAM) cooperates with RUNX2 and modulates enamel mineralization via regulation of MMP-20. J Cell Biochem (2010) 1.01
A feeder-free, defined three-dimensional polyethylene glycol-based extracellular matrix niche for culture of human embryonic stem cells. Biomaterials (2013) 0.99
Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun (2009) 0.99
Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer. J Clin Endocrinol Metab (2004) 0.99
A novel anti-neuroinflammatory pyridylimidazole compound KR-31360. Biochem Pharmacol (2010) 0.99
Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis. J Cell Physiol (2010) 0.96
Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Mol Cell Proteomics (2013) 0.96
NFI-C regulates osteoblast differentiation via control of osterix expression. Stem Cells (2014) 0.94
Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription. J Bone Miner Res (2011) 0.94
Role of soluble CD14 in cerebrospinal fluid as a regulator of glial functions. J Neurosci Res (2009) 0.94
Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med (2010) 0.93
Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86. J Biol Chem (2004) 0.92
Proteomic profile of osteoclast membrane proteins: identification of Na+/H+ exchanger domain containing 2 and its role in osteoclast fusion. Proteomics (2008) 0.92
Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis. J Cell Biochem (2012) 0.92
Molecular regulation of matrix extracellular phosphoglycoprotein expression by bone morphogenetic protein-2. J Biol Chem (2009) 0.91
Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev Dyn (2003) 0.90
Fucosylated glycoproteomic approach to identify a complement component 9 associated with squamous cell lung cancer (SQLC). J Proteomics (2011) 0.90
Upregulation of smpd3 via BMP2 stimulation and Runx2. BMB Rep (2009) 0.90
High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts. Bone (2011) 0.89
Proteomics analysis of human dentin reveals distinct protein expression profiles. J Proteome Res (2009) 0.88
FGF2 stimulates SDF-1 expression through the Erm transcription factor in Sertoli cells. J Cell Physiol (2009) 0.88
Shh and ROCK1 modulate the dynamic epithelial morphogenesis in circumvallate papilla development. Dev Biol (2008) 0.88
Spatio-temporal expression patterns of Runx2 isoforms in early skeletogenesis. Exp Mol Med (2002) 0.88
Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP. J Cell Physiol (2014) 0.87
Runx3 is a crucial regulator of alveolar differentiation and lung tumorigenesis in mice. Differentiation (2011) 0.87
Bone-related gene profiles in developing calvaria. Gene (2006) 0.87
The canonical BMP signaling pathway plays a crucial part in stimulation of dentin sialophosphoprotein expression by BMP-2. J Biol Chem (2010) 0.87
Regioselectivity prediction of CYP1A2-mediated phase I metabolism. J Chem Inf Model (2008) 0.87
Odontogenic differentiation of human dental pulp stem cells induced by preameloblast-derived factors. Biomaterials (2011) 0.86
N-acetylcysteine prevents LPS-induced pro-inflammatory cytokines and MMP2 production in gingival fibroblasts. Arch Pharm Res (2007) 0.86